CTGF AS TARGET MOLECULAR IN THE TREATMENT OF MICROAL BUMINURIA IN PATIENTS WITH DIABETIC NEPHROPATHY

摘要

The present invention relates to methods and compounds for treating specific early stage aspects and late stage aspects of diabetic nephropathy. Methods and compounds for treating various physiological features associated with early stage and with late stage diabetic nephropathy are also provided.